Altimmune (ALT) Depreciation & Amortization (CF) (2016 - 2025)
Altimmune (ALT) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $14000.0 as the latest value for Q4 2025.
- Quarterly Depreciation & Amortization (CF) fell 57.58% to $14000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Dec 2025, down 57.98% year-over-year, with the annual reading at $100000.0 for FY2025, 57.98% down from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 was $14000.0 at Altimmune, down from $27000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $285000.0 in Q3 2021, with the low at -$552000.0 in Q3 2023.
- Average Depreciation & Amortization (CF) over 5 years is -$30750.0, with a median of $35000.0 recorded in 2024.
- The sharpest move saw Depreciation & Amortization (CF) surged 291.02% in 2021, then tumbled 1052.83% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $117000.0 in 2021, then tumbled by 301.71% to -$236000.0 in 2022, then skyrocketed by 148.31% to $114000.0 in 2023, then plummeted by 71.05% to $33000.0 in 2024, then crashed by 57.58% to $14000.0 in 2025.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $14000.0, $27000.0, and $30000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.